MedPath

Comparison of fentanyl and nalbuphine in attenuating blood pressure and heart rate during laryngoscopy in patients undergoing general anaesthesia.

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/04/065626
Lead Sponsor
il
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Undergoing nasal intubation in oral and maxillofacial surgery.

Patient belonging to American society of Anaesthesiologist physical 1 and 2.

Exclusion Criteria

Age >60 or <18

Preoperative hypertension, coronary artery disease (CAD), cardiac conduction defects, congenial heart disease, hemodynamic instability and associated comorbidity.

Obesity ( body mass index >30 kg per square meter).

Mouth opening less than or equal to 2.5 fingers or inability to do laryngoscopy.

MPG grade 4.

Patients with nasal fracture.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compare the efficacy between nalbuphine and fentanyl in attenuating hemodynamic response to laryngoscopy and nasal intubation.Timepoint: Intraoperatively
Secondary Outcome Measures
NameTimeMethod
Compare Post operative sedation <br/ ><br>Compare post operative pain.Timepoint: Post operatively
© Copyright 2025. All Rights Reserved by MedPath